← Home
Lonza Group 
Pharma / Pharmaceutical and Biotechnology Manufacturing
👑 Owner Earnings
| Fiscal year | Owner Earnings per Share |
Owner Earnings | Average PPE | Growth CAPEX |
Maintenance CAPEX |
||
|---|---|---|---|---|---|---|---|
| 2025 | Q4 | CHF | -8.51 | -597.17M | 0.99506 | 679.21M | -1.38B |
| 2025 | Q2 | CHF | 2.87 | 201.54M | 0.99506 | -495.54M | -176.46M |
| 2024 | Q4 | CHF | 3.09 | 220.51M | 0.89314 | -246.51M | -548.49M |
| 2024 | Q2 | CHF | -0.70081 | -50.01M | 0.89314 | -66.99M | -555.01M |
| 2023 | ***** | ***** | ***** | ***** | ***** | ***** | ***** |
| 2023 | ***** | ***** | ***** | ***** | ***** | ***** | ***** |
| 2022 | ***** | ***** | ***** | ***** | ***** | ***** | ***** |
| 2022 | ***** | ***** | ***** | ***** | ***** | ***** | ***** |
💸 Explore more owner earnings data for Lonza Group!
Sign up for free or log in📥 Get our free eBook now: "The Checklist Value Investor — A Smarter Way to Pick Stocks"